Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/SUDEEPPHRM stock hub

NSE/SUDEEPPHRM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/SUDEEPPHRMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

74.3B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/SUDEEPPHRM

In the news

Latest news · NSE/SUDEEPPHRM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E38.3

P25 24.9P50 32.4P75 45.7

Trailing P/E42.7

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC19.1

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/SUDEEPPHRM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

137

Groups with data

Currency

INR

Showing 137 of 137 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	740
Employees Change	260%
Employees Change Percent	54.17
Enterprise value	INR 75.2B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE0QPI01025
Last refreshed	2026-05-10
Market cap	INR 74.3B
Price	INR 660
Price currency	INR
Rev Per Employee	12,863,870.83x
Sector	Healthcare
Sic	2833
Symbol	nse/SUDEEPPHRM
Website	https://www.sudeeppharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.26%
EV Earnings	44.72x
EV/EBIT	36.8x
EV/EBITDA	34.2x
EV/Sales	12.18x
Forward P/E	38.34x
P/B ratio	10.06x
P/E ratio	42.74x
P/S ratio	12.04x
PEG ratio	3.22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	33.1%
EBITDA Margin	35.48%
Gross margin	63.38%
Gross Profit	INR 3.9B
Gross Profit Growth	34.16%
Gross Profit Growth Q	44.52%
Net Income	INR 1.7B
Net Income Growth	26.27%
Net Income Growth Q	65.3%
Pretax Margin	36.15%
Profit Margin	27.24%
Profit Per Employee	INR 3.5M
ROIC	19.12
Roic5y	27.08

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth	25.39
EPS Growth Q	61.89
Revenue Growth	34.44x
Revenue Growth Q	49.16x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 676.2M
Debt	INR 1.4B
Debt EBITDA	INR 0.65
Debt Equity	INR 0.19
Equity	INR 7.4B
Interest Coverage	30.83
Net Cash	INR -751M
Net Cash By Market Cap	INR -1.01
Net Debt EBITDA	INR 0.34
Net Debt Equity	INR 0.1
Tangible Book Value	INR 6.6B
Tangible Book Value Per Share	INR 60.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.7%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	632
All Time High	795
All Time High Change	-16.98%
All Time High Date	2025-11-28
All Time Low	524.1
All Time Low Change	25.94%
All Time Low Date	2026-01-21
ATR	25.3
Beta1y	0.05
Ch YTD	9.5
High	679.8
High52	795
High52 Date	2025-11-28
High52ch	-16.98%
Low	655.1
Low52	524.1
Low52 Date	2026-01-21
Low52ch	25.94%
Ma50ch	4.43%
RSI	50.25
RSI Monthly	0
RSI Weekly	41.22
Sharpe ratio	-0.76x
Sortino ratio	-0.93
Total Return	-0.7%
Tr YTD	9.5
Tr1m	9.58%
Tr1w	-4.34%
Tr3m	3.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 2B
Operating Income Growth	18.17
Operating Income Growth Q	53.18
Operating margin	33.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	25,435,711%
Shares Insiders	37.13%
Shares Institutions	14.5%
Shares Out	112,948,625
Shares Qo Q	1.57%
Shares Yo Y	0.7%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	70,061.1x
Bv Per Share	66.5
Ch1m	9.58
Ch1w	-4.34
Ch3m	3.27
Change	-1.83%
Change From Open	-2.5
Close	672.3
Days Gap	0.69
Depreciation Amortization	147,303,000
Dollar Volume	52,779,540
Earnings Date	2026-08-06
EBIT	INR 2B
EBITDA	INR 2.2B
EPS	INR 15.4
F Score	1
Fiscal Year End	March
Founded	1,989
Graham Number	151.76791
Graham Upside	-77
Income Tax	INR 533M
Is Primary Listing	1
Last Earnings Date	2026-02-06
Last Report Date	2025-12-31
Ma20	663.1
Ma20ch	-0.46%
Next Earnings Date	2026-08-06
Open	677
Position In Range	19.84
Price Date	2026-05-08
Price EBITDA	INR 33.92
Ptbv Ratio	11.21
Relative Volume	0.83x
Revenue	6,174,658,000x
Tax By Revenue	8.63x
Tax Rate	23.88%
Volume	79,969

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/SUDEEPPHRM pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns NSE/SUDEEPPHRM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+14.5%

Share of float held by funds and institutions

Insider ownership

+37.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.7%

Negative means the company is buying back shares.

Technical

NSE/SUDEEPPHRM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.2

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.76

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/SUDEEPPHRM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/SUDEEPPHRM stock rating?

nse/SUDEEPPHRM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/SUDEEPPHRM analysis?

The full report lives at /stocks/nse/SUDEEPPHRM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/SUDEEPPHRM?

The latest report frames nse/SUDEEPPHRM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/SUDEEPPHRM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.